San Diego County is home to some of the best and brightest Alzheimer’s researchers and institutions. Every year, Alzheimer’s San Diego is honored to host them as they come together at Date With A Cure. This free research forum provides a rare opportunity to get your questions about dementia answered – by the very experts working to find a cure.
This year, the event will be held Tuesday, June 13th from 9 AM -11 AM via Zoom. The esteemed panel represents some of the most cutting-edge breakthroughs in disease pathology and caregiving strategies.
Dr. Paul S. Aisen
Director | USC Alzheimer’s Therapeutic Research Institute
Dr. Aisen is a professor of neurology and the founding director of USC Alzheimer’s Therapeutic Research Institute (ATRI). He has been a leading figure in Alzheimer’s disease research for more than two decades, having developed novel methodologies as well as designed and directed many large therapeutic trials. He has also authored more than 350 scientific papers.
Dr. James Brewer
Director | UCSD’s Shiley-Marcos Alzheimer’s Disease Research Center
Dr. Brewer chairs the UC San Diego Department of Neurosciences and directs the Shiley Marcos Alzheimer’s Disease Research Center. He joined UC San Diego after completing MD and PhD degrees at Stanford and neurology residency training at Johns Hopkins. His research program focuses on applying advanced brain imaging approaches to detect the subtle and progressive changes that accompany aging and neurodegenerative disease. Dr. Brewer has developed tools to support the detection of abnormal brain atrophy for patients being evaluated in the clinical setting and in clinical trials of new Alzheimer’s disease therapeutics and interventions.
Dr. Jerold Chun
Senior Vice President, Neuroscience Drug Discovery | Sanford Burnham Prebys Medical Discovery Institute
Dr. Chun received his degrees through the Medical Scientist Training Program at Stanford University, and as a Helen Hay Whitney Postdoctoral Fellow at the Whitehead Institute for Biomedical Research – MIT. He has made important contributions to our understanding of the brain and its diseases, including the discovery of genomic mosaicism in the brain and its involvement in the most common forms of Alzheimer’s disease with relevance to other brain diseases.
Dr. Douglas Galasko
Neurologist & Professor of Neurosciences | UC San Diego
Dr. Galasko is helping to refine the use of biomarkers, including blood tests, to identify brain changes in Alzheimer’s disease to facilitate early and accurate diagnosis. He also works on clinical trials aiming to apply novel strategies and drug approaches to innovate in the treatment landscape for Alzheimer’s disease. These trials range from lifestyle and behavioral interventions to novel drug approaches for prevention and in people with young onset Alzheimer’s disease.
Dr. Hector M. González
Professor of Neurosciences | UCSD School of Medicine
Hector M. González is a Professor of Neurosciences in the School of Medicine at the University of California, San Diego. Dr. González is a population neuroscientist and the Principal Investigator of the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA), which is the largest study of Latino cognitive aging, impairment and disorders among diverse Latinos.
Dr. Doris Molina-Henry
Assistant Professor, Research Neurology | USC Alzheimer’s Therapeutic Research Institute
Doris Molina-Henry, PhD is an Assistant Professor at the USC Keck School of Medicine Alzheimer’s Therapeutic Research Institute. Her work is focused on the science of recruitment aimed at increasing diverse participation into clinical trials. Currently, she works in increasing representation in trials that aim to prevent the symptoms of Alzheimer’s in individuals who are cognitively healthy but are at high risk for the disease in the future.
Dr. Michael Plopper
Medical Director | Sharp Clinical Research Center
Dr. Plopper, former chief medical officer of Sharp Behavioral Health Services for over 20 years, started the Clinical Research Program in 1995. He has served as principal investigator on over 200 psychiatric clinical trials for schizophrenia, Alzheimer’s disease, and other central nervous system disorders in adults and children.
Dr. Sherry Soefje
COO and Medical Director | Excell Research
Dr. Soefje is Co-Founder, Chief Financial Officer, and Medical Director of Excell Research. She brings close to 25 years of clinical trial experience, has participated in over 200 clinical trials in the CNS area, and has assumed the role as Principal Investigator for a majority of those trials since 2012.
We’ll see you at Date with a Cure on June 13th – bring your questions! Click here to register >>
